Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FOUR -11.4%, THS -11.3%, SWTX -10.6%, ANGI -8% (IAC also considering spin-off of its ownership stake), JRVR -7.1%, TME -6.6%, PLUG -4%, SLVM -3.6%, PGY -3.3%, ZETA -3.1%, NPWR -3.1%, NUVL -2%, GATO -1.7%, TALO -1.5%, FLNG -1.5%, AVDL -1.5%, AZN -1.2%, PLL -1.2%, VLN -1.1%
Other news:
- NGNE -33.6% (reports interim data from NGN-401 trial)
- SNDX -17.4% (pivotal topline results from relapsed or refractory mNPM1 AML cohort in AUGMENT-101 trial of revumenib)
- CWAN -4.9% (secondary public offering)
- KRUS -3.7% (stock offering)
- FWRG -3.1% (launches secondary offering by certain funds managed by Advent International of 8,000,000 shares of common stock)
- UPST -2.9% (proposes private offering of $425 mln of Convertible Senior Notes due 2030)
- TER -2% (increases share repurchase plan for 2024)
- FCPT -1.4% (raises quarterly dividend by 2.9% to $0.3550 per share)
- ALV -1.3% (raises dividend and extends share repurchase)
- IVZ -1.1% (prelim month-end AUM)
- CDXS -1% (to present data)